SAM
SPPI

Shell Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Shell Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-121,591
Closed -$265K – 1422
2021
Q3 		$265K Sell
121,591
-5,210
-4% -$14.2K 0.01% 1120
2021
Q2 		$476K Buy
126,801
+6,840
+6% +$23.8K 0.01% 940
2021
Q1 		$391K Buy
+119,961
New +$430K 0.01% 949
2019
Q2 		– Sell
-17,184
Closed -$184K – 1256
2019
Q1 		$184K Hold
17,184
– – ﹤0.01% 1117
2018
Q4 		$150K Sell
17,184
-1,400
-8% -$17.8K ﹤0.01% 1067
2018
Q3 		$312K Buy
+18,584
New +$402K 0.01% 1060

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shell Asset Management's SPPI Position: Q4 2021 in Review

Shell Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 121,591 shares — an estimated $265K sold.

Shell Asset Management first reported a position in SPPI in Q3 2018 and held it in 6 quarters. The position peaked at $476K in Q2 2021. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.

  • Shell Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Shell Asset Management sold 121,591 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $265K.
  • Shell Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 6 quarters.
  • Shell Asset Management's Spectrum Pharmaceuticals Inc position peaked at $476K in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.

Based on Shell Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.